HQ461
CAS No. 1226443-41-9
HQ461 ( —— )
Catalog No. M28932 CAS No. 1226443-41-9
HQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 49 | Get Quote |
|
5MG | 80 | Get Quote |
|
10MG | 140 | Get Quote |
|
25MG | 320 | Get Quote |
|
50MG | 537 | Get Quote |
|
100MG | 767 | Get Quote |
|
500MG | 1557 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHQ461
-
NoteResearch use only, not for human use.
-
Brief DescriptionHQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death.
-
DescriptionHQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1226443-41-9
-
Formula Weight345.4
-
Molecular FormulaC15H15N5OS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cnc(NC(=O)Cc2csc(Nc3cccc(C)n3)n2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dabir DV, et, al. A small molecule inhibitor of redox-regulated protein translocation into mitochondria. Dev Cell. 2013 Apr 15;25(1):81-92.
molnova catalog
related products
-
2-Chloropyrazine
2-Chloropyrazine is used in chemical industry.
-
BI-1347
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。
-
CDK5 inhibitor 20-22...
CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9.